← Back to Search

Speech Entrainment for Aphasia

N/A
Recruiting
Led By Marja-Liisa Mailend, PhD
Research Sponsored by Albert Einstein Healthcare Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between 18-80 years at the time of enrollment
English as native language
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one day post treatment
Awards & highlights

Study Summary

This trial looks at how speech entrainment can help people speak more efficiently and effectively. It tracks informativeness and efficiency of speech to measure outcomes.

Who is the study for?
This trial is for English-speaking adults aged 18-80 with aphasia, which affects their ability to communicate. They must be more than six months post-onset and have a specific score on the Western Aphasia Battery - Revised test. Participants need to commit to multiple sessions either at the testing site or at home.Check my eligibility
What is being tested?
The study tests two types of speech entrainment practices: audiovisual and auditory, to improve independent speech in people with aphasia. It measures how informative and efficient their speech is after treatment when telling stories.See study design
What are the potential side effects?
Since this trial involves practice-based interventions rather than medication, traditional side effects are not expected. However, participants may experience fatigue or frustration during the exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 80 years old.
Select...
English is my first language.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one day post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and one day post treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Correct Information Units per Minute
Secondary outcome measures
Number of Different Words per Minute

Trial Design

2Treatment groups
Experimental Treatment
Group I: Auditory Speech Entrainment PracticeExperimental Treatment2 Interventions
Auditory Speech Entrainment includes repeated practice of speaking synchronously with a recorded model, which provides contextual, temporal, and auditory cues for speaking.
Group II: Audiovisual Speech Entrainment PracticeExperimental Treatment2 Interventions
Audiovisual Speech Entrainment includes repeated practice of speaking synchronously with a recorded model, which provides contextual, temporal, and audiovisual cues for speaking.

Find a Location

Who is running the clinical trial?

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
330 Previous Clinical Trials
178,431 Total Patients Enrolled
37 Trials studying Aphasia
2,749 Patients Enrolled for Aphasia
Albert Einstein Healthcare NetworkLead Sponsor
64 Previous Clinical Trials
868,672 Total Patients Enrolled
2 Trials studying Aphasia
110 Patients Enrolled for Aphasia
Marja-Liisa Mailend, PhDPrincipal InvestigatorAlbert Einstein Healthcare Network

Media Library

Audiovisual Speech Entrainment Practice Clinical Trial Eligibility Overview. Trial Name: NCT05687994 — N/A
Aphasia Research Study Groups: Auditory Speech Entrainment Practice, Audiovisual Speech Entrainment Practice
Aphasia Clinical Trial 2023: Audiovisual Speech Entrainment Practice Highlights & Side Effects. Trial Name: NCT05687994 — N/A
Audiovisual Speech Entrainment Practice 2023 Treatment Timeline for Medical Study. Trial Name: NCT05687994 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age limitation for this trial restricted above 30 years old?

"In order to participate in this trial, patients must fall within the age limits of 18 and 80. Additionally, there is a total of 5 trials for minors and 87 studies available for persons over 65 years old."

Answered by AI

Are new participants able to join this research effort presently?

"The information on clinicaltrials.gov affirms that this particular trial is not presently recruiting patients, having been initially posted at the end of January 2023 and last updated early in the same month. Though no participants are being sought for it currently, there are 87 other medical studies actively searching for volunteers."

Answered by AI

Who are the eligible candidates for this experimental research?

"This clinical investigation is searching for 40 participants aged between 18-80 with aphasia. In order to be eligible, they must have English as their first language and meet the following prerequisites: experienced an onset of symptoms over 6 months ago, diagnosed using Western Aphasia Battery - Revised (WAB-R), score 7 or under on the Fluency subsection of the WAB-R, demonstrate enthusiasm and endurance to take part in multiple sessions either at MRRI testing site or remotely."

Answered by AI

Who else is applying?

What site did they apply to?
Moss Rehabilitation Research Institute
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Speech Entrainment Treatment for People With Aphasia
Marja-Liisa Mailend, PhD 2023. "Speech Entrainment Treatment for People With Aphasia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05687994.
All > Aphasia
~13 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top